AQR Arbitrage’s DermTech, Inc. Common Stock DMTK Stock Holding History

AQR Arbitrage’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-174,750	Closed	-$3.57M	–	580
2018 Q4	$3.57M	Hold	174,750	–	–	0.05%	207
2018 Q3	$3.54M	Hold	174,750	–	–	0.04%	212
2018 Q2	$3.48M	Sell	174,750 -150,000	-46%	-$2.98M	0.04%	203
2018 Q1	$6.41M	Hold	324,750	–	–	0.07%	162
2017 Q4	$6.31M	Sell	324,750 -25,250	-7%	-$492K	0.07%	153
2017 Q3	$6.8M	Buy	+350,000	New	+$6.81M	0.07%	156

Other funds holding DMTK

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

AQR Arbitrage's DMTK Position: Q1 2019 in Review

AQR Arbitrage sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2019, closing a stake of 174,750 shares — an estimated $3.57M sold.

AQR Arbitrage first reported a position in DMTK in Q3 2017 and held it in 6 quarters. The position peaked at $6.8M in Q3 2017. 5 funds tracked by Wall St. Rank hold DMTK as of Q1 2019.

AQR Arbitrage reported no remaining DermTech, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
AQR Arbitrage sold 174,750 DermTech, Inc. Common Stock shares in Q1 2019, an estimated $3.57M.
AQR Arbitrage first reported a position in DermTech, Inc. Common Stock in Q3 2017 and held it in 6 quarters.
AQR Arbitrage's DermTech, Inc. Common Stock position peaked at $6.8M in Q3 2017.
5 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2019.

Based on AQR Arbitrage's 13F filing for Q1 2019, filed 14 May 2019.